Variants of folate metabolism genes and risk of left-sided cardiac defects

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 88, Issue 1, 2010, Pages 48-53

  Mitchell, Laura E ^a   Long, Jin ^a   Garbarini, Jennifer ^b   Paluru, Prasuna ^b   Goldmuntz, Elizabeth ^b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Birth defect; Folate; Folic acid; Gene; Heart

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BETAINE HOMOCYSTEINE METHYLTRANSFERASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCOBALAMIN II;

AORTA COARCTATION; AORTA SUPRAVALVULAR STENOSIS; AORTA VALVE STENOSIS; ARTICLE; CONGENITAL HEART MALFORMATION; DEVELOPMENTAL GENE; FEMALE; FOLATE METABOLISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

EID: 75749099887     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20622     Document Type: Article

References (35)

1. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 57(1):289-300.
2. Boneva RS, Botto LD, Moore CA, et al. 2001. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 103(19):2376-2381.
3. Botto LD, Lin AE, Riehle-Colarusso T, et al. 2007. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 79(10):714-727.
4. Botto LD, Mulinare J, Erickson JD. 2000. Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol 151(9):878-884.
5. Botto LD, Mulinare J, Erickson JD. 2003. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 121A(2):95-101.
6. Boyles AL, Billups AV, Deak KL, et al. 2006. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 114(10):1547-1552.
7. Christianson A, Howson CP, Modell B. 2006. March of Dimes global report on birth defects. Available at: http://wwwmarchofdimescom/ MOD-Report-PFpdf.
8. Corone P, Bonaiti C, Feingold J, et al. 1983. Familial congenital heart disease: how are the various types related? Am J Cardiol 51(6):942-945.
9. Cripe L, Andelfinger G, Martin LJ, et al. 2004. Bicuspid aortic valve is heritable. J Am Coll Cardiol 44(1):138-143.
10. Doolin MT, Barbaux S, McDonnell M, et al. 2002. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 71(5):1222-1226.
11. Ferencz C, Boughman JA, Neill CA, et al. 1989. Congenital cardiovascular malformations: questions on inheritance: Baltimore-Washington Infant Study Group. J Am Coll Cardiol 14(3):756-763.
12. Ferencz C, Correa-Villasenor A, Loffredo CA, Wilson PD. 1997. Left-sided obstructive lesions. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington Infant Study: 1981-1989. Armonk: Futura Publishing Company. Chapter 8, pp. 166-227.
13. Fraser FC, Hunter AD. 1975. Etiologic relations among categories of congenital heart malformations. Am J Cardiol 36(6):793-796.
14. Gjessing HK, Lie RT. 2006. Case-parent triads: estimating single- and double-dose effects of fetal and maternal disease gene haplotypes. Ann Hum Genet 70(Pt 3):382-396.
15. Goldmuntz E, Woyciechowski S, Renstrom D, et al. 2008. Variants of folate metabolism and the risk of conotruncal cardiac defects. Circ Cardiovasc Genet 1:126-132.
16. Hinton RB Jr, Martin LJ, Tabangin ME, et al. 2007. Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol 50(16):1590-1595.
17. Hobbs CA, James SJ, Parsian A, et al. 2006. Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene. J Med Genet 43(2):162-166.
18. Jenkins KJ, Correa A, Feinstein JA, et al. 2007. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115(23):2995-3014.
19. Lewin MB, McBride KL, Pignatelli R, et al. 2004. Echocardiographic evaluation of asymptomatic parental and sibling cardiovascular anomalies associated with congenital left ventricular outflow tract lesions. Pediatrics 114(3):691-696.
20. McBride KL, Fernbach S, Menesses A, et al. 2004. A family-based association study of congenital left-sided heart malformations and 5,10 methylenetetrahydrofolate reductase. Birth Defects Res A Clin Mol Teratol 70(10):825-830.
21. McBride KL, Pignatelli R, Lewin M, et al. 2005. Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: segregation, multiplex relative risk, and heritability. Am J Med Genet A 134A(2):180-186.
22. Mitchell LE, Weinberg CR. 2005. Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the "pent" design. Am J Epidemiol 162(7):676-685.
23. Morin I, Platt R, Weisberg I, et al. 2003. Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet A 119A(2):172-176.
24. Mostowska A, Hozyasz KK, Jagodzinski PP. 2006. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population. Clin Genet 69(6):512-517.
25. Pei L, Zhu H, Zhu J, et al. 2006. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial defects and congenital heart defects in China. Ann Epidemiol 16(5):352-356.
26. Pierpont ME, Basson CT, Benson DW Jr, et al. 2007. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115(23):3015-3038.
27. Shaw GM, Iovannisci DM, Yang W, et al. 2005. Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A 138(1):21-26.
28. Shaw GM, Zhu H, Lammer EJ, et al. 2003. Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects. Am J Epidemiol 158(8):747-752.
29. van Beynum IM, den Heijer M, Blom HJ, Kapusta L. 2007. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 100(12):743-753.
30. van Beynum IM, Kouwenberg M, Kapusta L, et al. 2006. MTRR 66A>G polymorphism in relation to congenital heart defects. Clin Chem Lab Med 44(11):1317-1323.
31. van Beynum IM, Mooij C, Kapusta L, et al. 2008. Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects. Clin Chem Lab Med 46(10):1369-1375.
32. Verkleij-Hagoort AC, van Driel LM, Lindemans J, et al. 2008. Genetic and lifestyle factors related to the periconception vitamin B12 status and congenital heart defects: a Dutch case-control study. Mol Genet Metab 94(1):112-119.
33. Vermunt JK. 1997. LEM: a general program for the analysis of categorical data. Tilberg University.
34. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62(4):969-978.
35. Zhu H, Curry S, Wen S, et al. 2005. Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? Am J Med Genet A 135(3):274-277.